Search - tctmd.com

Displaying 141 - 160 of 427

Sort: Relevancy | Date

News Daily News

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Michael O'Riordan

July 03, 2025

News Conference News NY Valves 2025

Promising Early Data With Navitor TAVI Valves

Yael L. Maxwell

July 02, 2025

News Conference News NY Valves 2025

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

Yael L. Maxwell

July 01, 2025

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

News Conference News NY Valves 2025

Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE

Todd Neale

June 27, 2025

Presentation NY Valves 2025

One Year Results of a Clinical Study Using a Novel Polymeric Valve for Surgical Mitral Valve Replacement

Presenter: Isaac George

June 27, 2025

Presentation NY Valves 2025

Global and Regional Burden of Non-Rheumatic Degenerative Mitral Valve Disease: Implications for Transcatheter Therapies

Presenter: Guido Ascione

June 27, 2025

Presentation NY Valves 2025

Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry

Presenter: Santiago Garcia

June 27, 2025

Presentation NY Valves 2025

Two-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study

Presenter: Gilbert H. L. Tang

June 27, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

Presentation NY Valves 2025

Innovations in Pharmacotherapy – Focus on Factor XI Inhibitors

Presenter: Roxana Mehran

June 26, 2025

Presentation NY Valves 2025

Next Generation LAAC Device Development

Presenter: Horst Sievert

June 26, 2025

Presentation NY Valves 2025

Conformal

Presenter: Shephal K. Doshi

June 26, 2025

Presentation NY Valves 2025

AMULET NG

Presenter: Devi G. Nair

June 26, 2025

Presentation NY Valves 2025

Current Trials to Expand LAAC Clinical Indications

Presenter: Vivek Y. Reddy

June 26, 2025

Presentation NY Valves 2025

Prognostic Impact of Extra-Tricuspid Valve Involvement After Tricuspid Transcatheter Edge-to-Edge Repair: Insights from the Bronx Valve and TRISPA Registries

Presenter: Julio Echarte Morales

June 26, 2025

Presentation NY Valves 2025

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

Presenter: Suzanne V. Arnold

June 26, 2025

Presentation NY Valves 2025

TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement

Presenter: Paul A. Grayburn

June 26, 2025

Presentation NY Valves 2025

Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER

Presenter: Matthew J. Price

June 26, 2025

Presentation NY Valves 2025

What Are the Next Clinical Trials Needed in the Tricuspid Space?

Presenter: David J. Cohen

June 26, 2025

Advertisement

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Promising Early Data With Navitor TAVI Valves

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE

One Year Results of a Clinical Study Using a Novel Polymeric Valve for Surgical Mitral Valve Replacement

Global and Regional Burden of Non-Rheumatic Degenerative Mitral Valve Disease: Implications for Transcatheter Therapies

Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry

Two-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study

June 2025 Dispatch for the CV Team

Innovations in Pharmacotherapy – Focus on Factor XI Inhibitors

Next Generation LAAC Device Development

Conformal

AMULET NG

Current Trials to Expand LAAC Clinical Indications

Prognostic Impact of Extra-Tricuspid Valve Involvement After Tricuspid Transcatheter Edge-to-Edge Repair: Insights from the Bronx Valve and TRISPA Registries

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement

Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER

What Are the Next Clinical Trials Needed in the Tricuspid Space?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content